ArticlePLOS global public health2026
Factors associated with contraceptive use among reproductive-age women during a pandemic: Evidence from a small developing state.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic disrupted access to sexual and reproductive health services, including contraception, highlighting the need to understand contraceptive use to strengthen health-system resilience in small developing states. This study examined factors associated with contraceptive use among reproductive-age women during the early phase of the pandemic in Barbados. A cross-sectional online survey was conducted in 2020 among adults aged 18 years and older, with analysis restricted to non-pregnant women aged 18-49 years. Contraceptive use was assessed in relation to sociodemographic characteristics, relationship status, and psychosocial distress measured using the Hospital Anxiety and Depression Scale. Multiple imputation was used to address missing data, and sensitivity analyses compared imputed and complete-case models. Among 1,094 women, 34.2% (n = 333) reported current contraceptive use, while 36.5% reported moderate-to-severe anxiety and 39.0% reported clinically significant distress. In multivariable analyses, tertiary education (OR 1.68; 95% CI 1.24 - 2.28), being partnered but not cohabiting (OR 1.57; 95% CI 1.10 - 2.22), and being married or cohabiting (OR 2.49; 95% CI 1.65 - 3.77) were associated with higher odds of contraceptive use. Anxiety symptoms showed a weak positive association, while increasing age was associated with slightly lower odds. Findings were consistent across sensitivity analyses. These results underscore the importance of maintaining access to sexual and reproductive health services and integrating mental health support into emergency preparedness strategies.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.